Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
hydroxyurea
i
Other names:
WR 83799, NSC-32065, SQ-1089
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Generic mfg.
Drug class:
DNA synthesis inhibitor, Ribonucleotide reductase inhibitor
Related drugs:
‹
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
3-AP (1)
NSC-324360 (1)
imexon (0)
COH29 (0)
TAS1553 (0)
motexafin gadolinum (0)
cisplatin (330)
gemcitabine (181)
temozolomide (114)
cytarabine (99)
oxaliplatin (57)
dacarbazine (22)
cytarabine/daunorubicin liposomal formulation (19)
clofarabine (16)
carmustine (14)
mitomycin (10)
temozolomide gel (7)
nedaplatin (6)
fludarabine IV (6)
nelarabine (5)
bleomycin (4)
mercaptopurine (3)
thiotepa (3)
FF-10502 (2)
fotemustine (2)
streptozocin (2)
fludarabine oral (2)
thioguanine (2)
fosgemcitabine palabenamide (1)
asparagine cytarabine conjugate (1)
gemcitabine intravesical system (1)
mitomycin urothelial gel (1)
melphalan hepatic delivery system (1)
INT230-6 (1)
Ganfule (0)
liposomal cisplatin (0)
MKC-1106 (0)
miriplatin (0)
zinostatin (0)
pegylated liposomal mitomycin-c prodrug (0)
mercaptopurine oral suspension (0)
gemcitabine with RenovoCath (0)
cytarabine ocfosfate (0)
TG6002 (0)
dimesna (0)
mitomycin intravesicular (0)
SY-2101 (0)
captisol-enabled melphalan (0)
CO 1.01 (0)
D07001 (0)
TAS-118 (0)
PRV211 (0)
LP-100 (0)
PCS3117 (0)
PTX-200 (0)
3-AP (1)
NSC-324360 (1)
imexon (0)
COH29 (0)
TAS1553 (0)
motexafin gadolinum (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Oral Cancer
No biomarker
Oral Cancer
5-fluorouracil + hydroxyurea
Sensitive: A2 - Guideline
5-fluorouracil + hydroxyurea
Sensitive
:
A2
5-fluorouracil + hydroxyurea
Sensitive: A2 - Guideline
5-fluorouracil + hydroxyurea
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
5-fluorouracil + hydroxyurea
Sensitive: A2 - Guideline
5-fluorouracil + hydroxyurea
Sensitive
:
A2
5-fluorouracil + hydroxyurea
Sensitive: A2 - Guideline
5-fluorouracil + hydroxyurea
Sensitive
:
A2
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression
Acute Promyelocytic Leukemia
FLT3-ITD mutation + PML-RARA fusion + WT1 overexpression
Acute Promyelocytic Leukemia
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive: C4 – Case Studies
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive
:
C4
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive: C4 – Case Studies
cytarabine + idarubicin hydrochloride + arsenic trioxide + hydroxyurea
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.